Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental radioimmunotherapy. A brief overview

R L Wahl1

  • 1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0028.

Cancer
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022
Same author

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.

European journal of nuclear medicine and molecular imaging·2022
Same author

Factors affecting the repeatability of gamma camera calibration for quantitative imaging applications using a sealed source.

Physics in medicine and biology·2015
Same author

Understanding the Role of 18Flurodeoxyglucose PET in Predicting Improved Survival in Locally Advanced Pancreatic Cancer.

Practical radiation oncology·2014
Same author

EQPlanar: a maximum-likelihood method for accurate organ activity estimation from whole body planar projections.

Physics in medicine and biology·2011
Same author

Molecular imaging in thyroid cancer.

Cancer imaging : the official publication of the International Cancer Imaging Society·2010
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Experimental models are crucial for selecting promising monoclonal antibodies and radiolabels for radioimmunotherapy. Recognizing animal model limitations is key for translating findings to human clinical trials.

Area of Science:

  • Oncology
  • Immunology
  • Radiochemistry

Background:

  • Radioimmunotherapy (RIT) utilizes targeted antibodies and radioisotopes for cancer treatment.
  • Preclinical experimental models are essential for evaluating RIT agents and strategies.

Purpose of the Study:

  • To review the utility of experimental models in RIT research.
  • To discuss the selection of monoclonal antibodies and radiolabels for RIT.
  • To highlight limitations of animal models in RIT studies.

Main Methods:

  • Overview of experimental models used in RIT research.
  • Discussion of therapeutic approaches studied in these models.
  • Analysis of interspecies differences impacting data extrapolation.

Related Experiment Videos

Main Results:

  • Experimental models aid in selecting promising monoclonal antibodies and radiolabels for RIT.
  • Various RIT therapeutic approaches are being investigated in preclinical settings.
  • Allometric and other differences between species present limitations for direct translation of animal data to humans.

Conclusions:

  • Experimental models are valuable for initial RIT innovation testing.
  • Understanding model limitations is critical for successful clinical translation of RIT.
  • Continued use of experimental models is vital for advancing RIT strategies.